Neola Medical: Approved clinical study in Sweden - Redeye
Bildkälla: Stockfoto

Neola Medical: Approved clinical study in Sweden - Redeye

Redeye comments on Neola Medical’s approved clinical study in Sweden, which is expected to run for approximately four months and serve as a preparatory step for the upcoming US clinical trial. We also look ahead to the company’s Q4 2024 report, set for release tomorrow.

Redeye comments on Neola Medical’s approved clinical study in Sweden, which is expected to run for approximately four months and serve as a preparatory step for the upcoming US clinical trial. We also look ahead to the company’s Q4 2024 report, set for release tomorrow.
Börsvärldens nyhetsbrev
ANNONSER